Democrats’ Assault on Americans’ Healthcare Just Getting Started
August 18, 2022 Gerard Scimeca Chairman, CASE As President Biden and Democrats celebrate their reconciliation “victory,” American patients are...
CASE Op-Ed – RealClearHealth: Biden Administration Is Using Inflation to Masquerade Their Drug Pricing Schemes
July 26, 2022 The midterms are less than five months away, and with President Biden’s approval numbers at a historic...
Rep. Dan Crenshaw Breaks Down Why H.R.3 is a Dangerous Idea
“I don’t think people would be supportive of this idea if they realized there would be so many fewer cures.”...
In The House of Representatives – Few Cures, Many Ills on Drug Pricing
Yesterday, the House Energy and Commerce Committee debated the merits of H.R.3, a proposal released by Speaker of the House...
Pelosi’s Drug Pricing Plan Is A Giant Leap Towards Socialism
September 12, 2019 Earlier this week, a draft of Speaker of the House Nancy Pelosi’s drug pricing plan was leaked...
CASE Launches TV Ad Urging Senators NOT to Raid Medicare Part D
(Arlington, Virginia) — CASE launches new ad imploring the Senate to abandon a proposal that would place inflationary price caps...
Inflationary Price Caps are a Tax on Medicare Part D and Won’t Help Seniors with Drug Costs
July 19, 2019 We recently learned that the White House is asking Senate Democrats to include two proposals in...
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/